On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Ohio Employers, Be Ready: The Paystub Protection Act Takes Effect Soon
- Video: Should Employers Shift Workforce Data Collection Under President Trump? - Employment Law This Week
- New Tennessee Immigration Enforcement Law: Key Measures and Implications
- Video: Workplace Law Shake-Up - DEI Challenges, NLRB Reversals, and EEOC Actions - Employment Law This Week
- California’s AI Revolution: Proposed CPPA Regulations Target Automated Decision Making